XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Preferred stock
Series X redeemable convertible preferred stock
Common stock
Underwriting agreement
Common stock
at-the-market offerings
Common stock
Additional paid-in capital
Underwriting agreement
Additional paid-in capital
at-the-market offerings
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Underwriting agreement
at-the-market offerings
Total
Beginning balance at Dec. 31, 2023 $ 95,324     $ 41     $ 728,285 $ (580,534) $ 0     $ 243,116
Beginning balance (in shares) at Dec. 31, 2023 31,107     41,034,797                
Increase (Decrease) in Shareholders' Equity                        
Issuance of common stock, net of issuance costs   $ 10 $ 3   $ 117,162 $ 19,999       $ 117,172 $ 20,002  
Issuance of common stock net of issuance costs (in shares)   10,340,000 2,945,806                  
Issuance of common stock upon exercise of options and warrants       $ 1     4,632         4,633
Issuance of common stock upon exercise of options and warrants (in shares)       582,458                
Stock-based compensation expense             2,754         2,754
Unrealized loss on short-term investments                 (14)     (14)
Net loss               (19,928)       (19,928)
Ending balance at Mar. 31, 2024 $ 95,324     $ 55     872,832 (600,462) (14)     367,735
Ending balance (in shares) at Mar. 31, 2024 31,107     54,903,061                
Beginning balance at Dec. 31, 2024 $ 95,324     $ 57     898,513 (674,794) 163     319,263
Beginning balance (in shares) at Dec. 31, 2024 31,107     56,434,219                
Increase (Decrease) in Shareholders' Equity                        
Stock-based compensation expense             3,839         3,839
Unrealized loss on short-term investments                 (103)     (103)
Net loss               (33,709)       (33,709)
Ending balance at Mar. 31, 2025 $ 95,324     $ 57     $ 902,352 $ (708,503) $ 60     $ 289,290
Ending balance (in shares) at Mar. 31, 2025 31,107     56,434,219